The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Regulation of Hypoxia-induced Pulmonary Hypertension by Vascular Smooth Muscle Hypoxia-Inducible Factor-1α
Open accessAbstract
RATIONALE: Chronic hypoxia induces pulmonary vascular remodeling, pulmonary hypertension, and right ventricular hypertrophy. At present, little is known about mechanisms driving these responses. Hypoxia-inducible factor-1α (HIF-1α) is a master regulator of transcription in hypoxic cells, up-regulating genes involved in energy metabolism, proliferation, and extracellular matrix reorganization. Systemic loss of a single HIF-1α allele has been shown to attenuate hypoxic pulmonary hypertension, but the cells contributing to this response have not been identified. OBJECTIVES: We sought to determine the contribution of HIF-1α in smooth muscle on pulmonary vascular and right heart responses to chronic hypoxia. METHODS: We used mice with homozygous conditional deletion of HIF-1α combined with tamoxifen-inducible smooth muscle-specific Cre recombinase expression. Mice received either tamoxifen or vehicle followed by exposure to either normoxia or chronic hypoxia (10% O2) for 30 days before measurement of cardiopulmonary responses. MEASUREMENTS AND MAIN RESULTS: Tamoxifen-induced smooth muscle-specific deletion of HIF-1α attenuated pulmonary vascular remodeling and pulmonary hypertension in chronic hypoxia. However, right ventricular hypertrophy was unchanged despite attenuated pulmonary pressures. CONCLUSIONS: These results indicate that HIF-1α in smooth muscle contributes to pulmonary vascular remodeling and pulmonary hypertension in chronic hypoxia. However, loss of HIF-1 function in smooth muscle does not affect hypoxic cardiac remodeling, suggesting that the cardiac hypertrophy response is not directly coupled to the increase in pulmonary artery pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms
Stenmark, K. R., Fagan, K. A., & Frid, M. G. (2006) · Circulation Research · doi:10.1161/01.res.0000243584.45145.3f · Cited by 1,006
Semenza, G. L., Nejfelt, M. K., Chi, S. M., & Antonarakis, S. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5680 · Cited by 990
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 890
TARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
Pacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., & Kass, D. A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.138 · Cited by 734 · cited 1×
“(Millar Instruments, Houston, TX) using a modification of a previous technique (33).”
MethodG12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension
Wirth, A., Benyó, Z., Lukasova, M., Leutgeb, B., Wettschureck, N., Gorbey, S., Örsy, P., Horváth, B., Maser-Gluth, C., Greiner, E., et al. (2008) · Nature Medicine · doi:10.1038/nm1666 · Cited by 681
Yu, A. Y., Shimoda, L. A., Iyer, N. V., Huso, D. L., Sun, X., McWilliams, R., Beaty, T., Sham, J. S. K., Wiener, C. M., Sylvester, J. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5912 · Cited by 656
Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure
Bogaard, H. J., Natarajan, R., Henderson, S. C., Long, C. S., Kraskauskas, D., Smithson, L., Ockaili, R., McCord, J. M., & Voelkel, N. F. (2009) · Circulation · doi:10.1161/circulationaha.109.883843 · Cited by 513
LUNG VASCULAR DEVELOPMENT: Implications for the Pathogenesis of Bronchopulmonary Dysplasia
Stenmark, K. R., & Abman, S. H. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.102229 · Cited by 378
Kline, D. D., Peng, Y.-J., Manalo, D. J., Semenza, G. L., & Prabhakar, N. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022634199 · Cited by 263
The effects of hypoxia on the cells of the pulmonary vasculature
Pak, O., Aldashev, A., Welsh, D., & Peacock, A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00128706 · Cited by 224
Inhibition of Rho-Kinase Attenuates Hypoxia-Induced Angiogenesis in the Pulmonary Circulation
Hyvelin, J.-M., Howell, K., Nichol, A., Costello, C. M., Preston, R. J., & McLoughlin, P. (2005) · Circulation Research · doi:10.1161/01.res.0000174287.17953.83 · Cited by 207
Pulmonary Hypertension and Right Heart Failure in Chronic Obstructive Pulmonary Disease
Naeije, R. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200407-037ms · Cited by 202
Shimoda, L. A., Fallon, M., Pisarcik, S., Wang, J., & Semenza, G. L. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00528.2005 · Cited by 202
Shimoda, L. A., Manalo, D. J., Sham, J. S. K., Semenza, G. L., & Sylvester, J. T. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l202 · Cited by 201
Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular Remodeling
Taraseviciene-Stewart, L., Nicolls, M. R., Kraskauskas, D., Scerbavicius, R., Burns, N., Cool, C., Wood, K., Parr, J. E., Boackle, S. A., & Voelkel, N. F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1189oc · Cited by 182
Gleadle, J. M., & Ratcliffe, P. J. (1997) · Blood · doi:10.1182/blood.v89.2.503 · Cited by 181
Thibault, H. B., Kurtz, B., Raher, M. J., Shaik, R. S., Waxman, A., Derumeaux, G., Halpern, E. F., Bloch, K. D., & Scherrer-Crosbie, M. (2010) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.109.887109 · Cited by 180
Hypoxic Activation of Adventitial Fibroblasts*
Stenmark, K. R., Gerasimovskaya, E., Nemenoff, R. A., & Das, M. (2002) · Chest · doi:10.1378/chest.122.6_suppl.326s · Cited by 172
The Role of NADPH Oxidase in Chronic Intermittent Hypoxia-Induced Pulmonary Hypertension in Mice
Nisbet, R. E., Graves, A. S., Kleinhenz, D. J., Rupnow, H. L., Reed, A. L., Fan, T.-H. M., Mitchell, P. O., Sutliff, R. L., & Hart, C. M. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/2008-0145oc · Cited by 167
Schultz, K., Fanburg, B. L., & Beasley, D. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01077.2005 · Cited by 159
The von Hippel–Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice
Hickey, M. M., Richardson, T., Wang, T., Mosqueira, M., Arguiri, E., Yu, H. D., Yu, Q., Solomides, C., Morrisey, E. E., Khurana, T. S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36362 · Cited by 153
Partovian, C., Adnot, S., Eddahibi, S., Teíger, E., Levame, M., Dreyfus, P. A., Raffestin, B., & Frelin, C. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.6.h1948 · Cited by 151
Faber, M. J., Dalinghaus, M., Lankhuizen, I. M., Steendijk, P., Hop, W. C. J., Schoemaker, R. G., Duncker, D. J., Lamers, J. M. J., & Helbing, W. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00286.2006 · Cited by 140
Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia
Fagan, K. A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.6.2502 · Cited by 125
Rose, F., Grimminger, F., Appel, J., Heller, M., Pies, V., Weißmann, N., Fink, L., Schmidt, S., Krick, S., Camenisch, G., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0420fje · Cited by 115
Hayashida, K., Fujita, J., Miyake, Y., Kawada, H., Ando, K., Ogawa, S., & Fukuda, K. (2005) · CHEST Journal · doi:10.1378/chest.127.5.1793 · Cited by 108
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
Abud, E. M., Maylor, J., Undem, C., Punjabi, A. N., Zaiman, A., Myers, A. C., Sylvester, J. T., Semenza, G. L., & Shimoda, L. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120385109 · Cited by 103
Impairment of hypoxic pulmonary artery remodeling by heparin in mice.
Hales, C. A., Kradin, R. L., Brandstetter, R. D., & Zhu, Y. J. (1983) · PubMed · doi:10.1164/arrd.1983.128.4.747 · Cited by 92
Fan, C., Iacobaş, D. A., Zhou, D., Chen, Q., Lai, J. C. K., Gavrialov, O., & Haddad, G. G. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00217.2004 · Cited by 89
Davie, N. J., Gerasimovskaya, E. V., Hofmeister, S. E., Richman, A. P., Jones, P. L., Reeves, J. Τ., & Stenmark, K. R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050754 · Cited by 85
Stern, R. C. (1980) · American journal of diseases of children · doi:10.1001/archpedi.1980.02130150025007 · Cited by 84
The a“MAZE”ing World of Lung-Specific Transgenic Mice
Rawlins, E. L., & Perl, A. T. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0372ps · Cited by 81
Kim, Y.-M., Barnes, E. A., Alvira, C. M., Ying, L., Reddy, S., & Cornfield, D. N. (2013) · Circulation Research · doi:10.1161/circresaha.112.300646 · Cited by 75
Bohuslavová, R., Kolář, F., Kuthanová, L., Neckář, J., Tichopád, A., & Pavlínková, G. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00366.2010 · Cited by 53
Toll-like receptor 4–deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension
Young, K. C., Hussein, S., Dadiz, R., deMello, D. E., Devia, C., Hehre, D., & Suguihara, C. (2010) · Experimental Lung Research · doi:10.3109/01902140903171610 · Cited by 47
Chronic hypoxia induces right heart failure in caveolin-1−/− mice
Cruz, J. A., Bauer, E. M., Rodriguez, A. I., Gangopadhyay, A., Zeineh, N. S., Wang, Y., Shiva, S., Champion, H. C., & Bauer, P. M. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01140.2011 · Cited by 39
Secondary pulmonary hypertension
Roy, R., & Couriel, J. (2006) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2005.11.004 · Cited by 36
Iacobaş, D. A., Fan, C., Iacobaş, S., & Haddad, G. G. (2008) · Functional & Integrative Genomics · doi:10.1007/s10142-008-0082-y · Cited by 35
Cited by
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Humbert, M., Guignabert, C., Bonnet, S., Dorfmüller, P., Klinger, J. R., Nicolls, M. R., Olschewski, A. J., Pullamsetti, S. S., Schermuly, R. T., Stenmark, K. R., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01887-2018 · Cited by 1,281
Hypoxia signaling in human diseases and therapeutic targets
Lee, J. W., Ko, J., Ju, C., & Eltzschig, H. K. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0235-1 · Cited by 384
Hypoxia-inducible factor signaling in pulmonary hypertension
Pullamsetti, S. S., Mamazhakypov, A., Weissmann, N., Seeger, W., & Savai, R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137558 · Cited by 234
“reported that SMC-specific postnatal (inducible) deletion of Hif1a attenuated PH but did not affect RV hypertrophy (100).”
BackgroundCD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension
Luo, Y., Teng, X., Zhang, L., Chen, J., Liu, Z., Chen, X., Zhao, S., Yang, S., Feng, J., & Yan, X. (2019) · Nature Communications · doi:10.1038/s41467-019-11500-6 · Cited by 121
Roles of HIF1 and HIF2 in pulmonary hypertension: it all depends on the context
Waypa, G. B., & Schumacker, P. T. (2019) · European Respiratory Journal · doi:10.1183/13993003.01929-2019 · Cited by 26
Self-citation
Metadata
- Authors
- Ball, M. K., Waypa, G. B., Mungai, P. T., Nielsen, J. M., Czech, L., Dudley, V. J., Beussink, L., Dettman, R. W., Berkelhamer, S. K., Steinhorn, R. H., Shah, S. J., & Schumacker, P. T.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-01
- Volume
- 189
- Issue
- 3
- Pages
- 314-324
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1980111004
- Cited by
- 265
- References
- 44
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.